Brain47Brain47Join Brain47
46K

IRadimed Corporation

Healthcare · EUR · F

46K

Price

€79.38

+2.44%

Cap

€1.10B

Earnings

—

30d Trend

+5.1%

46K
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range77%
€44.03€90.14

Upper half of range — momentum is positive

VolatilityModerate

33% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level55
Quality84
Momentum43
Technical52
Fundamentals22

Raw weighted: 57×Macro 0.99 (−1%)=56

RISK LEVEL

55/100
90d Volatility
33.3%Moderate
ATR %
3.5%High daily moves
Max Drawdown (1Y)
-20.6%Normal

QUALITY

84/100
ROE (avg)
25.0%Excellent
Piotroski F-Score
6/9Average
Margin Stability
CV 0.5%Very stable
Accruals
-2.3%Cash earnings

MOMENTUM

43/100
6-1M Momentum
-8.3%Negative
1M Return
+8.3%Strong recent gains
Relative Strength
+0.6% vs sectorIn-line

TECHNICAL

52/100
RSI (14)
54.5Neutral
Price vs SMA200
+5.0%Bullish trend
MACD
+0.43Bullish momentum
Bollinger Band
64%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.233Noisy/choppy

FUNDAMENTALS

22/100
EV/EBIT
40.2Expensive
P/FCF
64.2Expensive
P/S
12.8Expensive
PEG
4.46Overpriced growth
Shareholder Yield
1.4%Low

Macro: neutral (×0.99) - Fear/Greed: 61 (Greed) - Data: 100%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months ★54
3-12 months45
1-5+ years48

Limited short-term thesis

BRAIN47'S ASSESSMENT

I rate IRadimed Corporation at 56/100 — a STRONG reading on the Brain47 Signal. The strongest factor is quality at 84/100. I classify this as a income position with the strongest thesis on a short-term horizon.

PAST PERFORMANCE

1 MONTH

+8.3%

3 MONTHS

-8.7%

12 MONTHS

—

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

Limited short-term thesis. Quality (84) and Technical (52) are the primary strengths. I note that fundamentals is the weakest area at 22/100 — this warrants monitoring. Historical volatility is moderate at 33%. I classify this as an income position — the 1.4% yield combined with the dividend profile makes it suitable for income generation.

incomeScore: 56/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.